专利号:US-5286744-A 优先权日:1991-08-22 标题:N-sulfonyl-tetrahydro-[1,3]-dioxepino[5,6-biazirines, intermediates for their preparation and their use 发明人:DUMIC MILJENKO; FILIC DARKO; VINKOVI MLADEN; JAMNICKY BLANKA 权利人:PLIVA HANDELS GMBH; PLIVA PHARM & CHEM WORKS 摘要:Starting from cis-2-butene-1,4-diol, via the 4,7-dihydro-1,3-dioxepin and trans-6-acylamino-5-chloro-1,3-dioxepans the novel tetrahydro-(1,3)-dioxepino(5,6-b)-azirines were synthesized, and therefrom the novel hypoglycaemically active N-sulfonyl-tetrahydro-(1,3)-dioxepino(5,6-b)azirines. The inventive compounds are valuable intermediates in the synthesis of other, biologically active substances.
1: Lin H, Zheng M, Mao X, Feng X, Li J, Rao G, Lin F. Oxytocin treatment prevents marrow adiposity observed in alloxan-induced diabetic rabbits using proton MR spectroscopy. Endokrynol Pol. 2018 Jun 28. doi: 10.5603/EP.a2018.0040. [Epub ahead of print] Comparison of Acute Gene Expression Profiles of Islet Cells Obtained via Laser Capture Microdissection between Alloxan- and Streptozotocin-treated Rats. Toxicol Pathol. 2018 Jan 1:192623318783957. doi: 10.1177/0192623318783957. [Epub ahead of print]
合成参考文献
参考文献:10.1007/bf00278752 摘要:Koltai MZ, Rösen P, Hadházy P, Ballagi-Pordány G, Köszeghy A, Pogátsa G. Relationship between vascular adrenergic receptors and prostaglandin biosyntheses in canine diabetic coronary arteries. Diabetologia. 1988 Sep;31(9):681–6. doi: 10.1007/bf00278752.